Small cell lung cancer I–III A: cytoreductive chemotherapy followed by resection with continuation of chemotherapy

Abstract

Satisfactory local tumor control confirmed the assumption of the study. No residual tumor in the resected specimen (pCR) is the most favorable prognostic factor and determinant of long-term survival. Surgery should not be performed in the patients with persistent N2 disease.